Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 2
2015 6
2016 4
2017 6
2018 6
2019 3
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
Haagmans BL, van den Brand JM, Raj VS, Volz A, Wohlsein P, Smits SL, Schipper D, Bestebroer TM, Okba N, Fux R, Bensaid A, Solanes Foz D, Kuiken T, Baumgärtner W, Segalés J, Sutter G, Osterhaus AD. Haagmans BL, et al. Among authors: fux r. Science. 2016 Jan 1;351(6268):77-81. doi: 10.1126/science.aad1283. Epub 2015 Dec 17. Science. 2016. PMID: 26678878 Free article.
Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.
Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A. Altenburg AF, et al. Among authors: fux r. Viruses. 2014 Jul 17;6(7):2735-61. doi: 10.3390/v6072735. Viruses. 2014. PMID: 25036462 Free PMC article. Review.
CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
Veit S, Jany S, Fux R, Sutter G, Volz A. Veit S, et al. Among authors: fux r. Viruses. 2018 Dec 16;10(12):718. doi: 10.3390/v10120718. Viruses. 2018. PMID: 30558354 Free PMC article.
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.
Song F, Fux R, Provacia LB, Volz A, Eickmann M, Becker S, Osterhaus AD, Haagmans BL, Sutter G. Song F, et al. Among authors: fux r. J Virol. 2013 Nov;87(21):11950-4. doi: 10.1128/JVI.01672-13. Epub 2013 Aug 28. J Virol. 2013. PMID: 23986586 Free PMC article.
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
Volz A, Kupke A, Song F, Jany S, Fux R, Shams-Eldin H, Schmidt J, Becker C, Eickmann M, Becker S, Sutter G. Volz A, et al. Among authors: fux r. J Virol. 2015 Aug;89(16):8651-6. doi: 10.1128/JVI.00614-15. Epub 2015 May 27. J Virol. 2015. PMID: 26018172 Free PMC article.
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM. Koch T, et al. Among authors: fux r. Lancet Infect Dis. 2020 Jul;20(7):827-838. doi: 10.1016/S1473-3099(20)30248-6. Epub 2020 Apr 21. Lancet Infect Dis. 2020. PMID: 32325037 Free PMC article. Clinical Trial.
Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S.
Langenmayer MC, Lülf-Averhoff AT, Adam-Neumair S, Fux R, Sutter G, Volz A. Langenmayer MC, et al. Among authors: fux r. Biologicals. 2018 Jul;54:58-62. doi: 10.1016/j.biologicals.2018.05.004. Biologicals. 2018. PMID: 29759890 Free PMC article.
Cross-sectional study on viraemia and shedding of porcine circovirus type 2 in a subclinically infected multiplier sow herd.
Eddicks M, Beuter B, Stuhldreier R, Nolte T, Reese S, Sutter G, Ritzmann M, Fux R. Eddicks M, et al. Among authors: fux r. Vet Rec. 2019 Feb 9;184(6):189. doi: 10.1136/vr.105069. Epub 2018 Nov 9. Vet Rec. 2019. PMID: 30413676
Full genome characterization of porcine circovirus type 3 isolates reveals the existence of two distinct groups of virus strains.
Fux R, Söckler C, Link EK, Renken C, Krejci R, Sutter G, Ritzmann M, Eddicks M. Fux R, et al. Virol J. 2018 Jan 29;15(1):25. doi: 10.1186/s12985-018-0929-3. Virol J. 2018. PMID: 29378597 Free PMC article.
N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.
Wernike K, Mundt A, Link EK, Aebischer A, Schlotthauer F, Sutter G, Fux R, Beer M. Wernike K, et al. Among authors: fux r. Vaccine. 2018 Aug 16;36(34):5116-5123. doi: 10.1016/j.vaccine.2018.07.047. Epub 2018 Jul 23. Vaccine. 2018. PMID: 30049630
28 results
Jump to page
Feedback